Reoperation for prosthetic aortic valve obstruction in the era of echocardiography: trends in diagnostic testing and comparison with surgical findings  by Girard, Steven E et al.
Reoperation for Prosthetic Aortic Valve Obstruction
in the Era of Echocardiography: Trends in Diagnostic
Testing and Comparison With Surgical Findings
Steven E. Girard, MD, PHD,* Fletcher A. Miller, Jr., MD, FACC*, Thomas A. Orszulak, MD,†
Charles J. Mullany, MD,† Samantha Montgomery, MS,‡ William D. Edwards, MD,§
Henry D. Tazelaar, MD,§ Joseph F. Malouf, MD, FACC,* A. Jamil Tajik, MD, FACC*
Rochester, Minnesota
OBJECTIVES We sought to: 1) identify trends in the diagnostic testing of patients with prosthetic aortic
valve (AVR) obstruction who undergo reoperation and 2) compare diagnostic test results with
pathologic findings at surgery.
BACKGROUND It is unclear whether Doppler transthoracic echocardiography (TTE) and transesophageal
echocardiography (TEE) have reduced hemodynamic catheterization rates.
METHODS We reviewed 92 consecutive cases of AVR reoperation at a single center from 1989 to 1998,
comparing 49 cases of mechanical AVR obstruction (group A) to 43 cases of bioprosthetic
obstruction (group B). Preoperative Doppler TTE was performed in all cases.
RESULTS In group A cases, there was a marginally significant trend towards lower catheterization rates
for the Gorlin AVR area, from 36% in 1989 to 1990 to 10% in 1997 to 1998 (p 5 0.07), but
diagnostic TEE utilization (47% of cases) did not vary. The cause of mechanical AVR
obstruction was pannus in 26 cases (53%), mismatch (P-PM) in 19 (39%) and thrombosis in
4 (8%). The mechanism (pannus/thrombus vs. mismatch) was identified in 10% by TTE and
49% by TEE (p , 0.001). In group B cases, hemodynamic catheterization rates (21%) and
diagnostic TEE utilization (21%) did not vary with time. Obstruction was caused by
structural degeneration in 37 cases (86%), thrombosis in 3 (7%), mismatch in 2 (5%) and
pannus in 1 (2%). The mechanism was correctly identified in 63% by TTE and in 81% by
TEE (p 5 0.18).
CONCLUSIONS Doppler TTE is the primary means to diagnose AVR obstruction; hemodynamic catheter-
ization is not routinely needed. In unselected patients with mechanical AVR obstruction,
TEE differentiation of pannus or thrombus from mismatch is challenging. (J Am Coll
Cardiol 2001;37:579–84) © 2001 by the American College of Cardiology
Reoperation for prosthetic valve dysfunction has been asso-
ciated with significant mortality, particularly in patients
undergoing urgent or emergency procedures (1,2). There-
fore, the identification of prosthetic obstruction prior to the
development of severe symptoms is advocated. Transthoracic
echocardiography (TTE) with Doppler hemodynamics is now
a widely available, validated technique to assess prosthetic
function, particularly in serial fashion (3). Likewise, transesoph-
ageal echocardiographic (TEE) technology has rapidly evolved
(4). We hypothesized that, over the past decade, these echo-
cardiographic advances have resulted in important changes in
the clinical management of patients with prosthetic aortic valve
(AVR) obstruction. Furthermore, we sought to establish the
diagnostic accuracy of TTE and TEE for determining the
etiology of prosthetic AVR obstruction.
METHODS
Study patients. The research protocol was approved by the
Institutional Review Board of the Mayo Foundation. There
were 368 repeat aortic valve procedures at Mayo Clinic
Rochester, Minnesota, from 1989 through 1998. We ex-
cluded patients who refused consent for research authoriza-
tion and those with complex cyanotic heart disease, valved
conduits and active endocarditis. Among 312 cases without
an exclusion, we identified 92 with AVR obstruction ac-
cording to pretreatment echocardiographic or catheteriza-
tion hemodynamics. “Obstruction” was defined as a mean
AVR gradient .1 standard deviation above the normal
value and an effective orifice area (EOA) at least 1 standard
deviation below the normal value for prosthetic type and
size (5). We divided the study cohort into 2 groups for
analysis: 49 cases of reoperation for mechanical AVR
obstruction in group A; and 43 cases of reoperation for
bioprosthetic AVR obstruction in group B.
Echocardiography. Transthoracic echocardiography stud-
ies were performed in all patients and included two-
dimensional, color-flow and Doppler examinations using
commercially available systems and published methods
(6,7). The mean prosthetic AVR gradient was determined
using the short form of the modified Bernoulli equation,
and the prosthetic EOA was estimated using the velocity
modification of the continuity equation (8,9). Based on the
interpretation of a staff echocardiologist, we reported one of
the following mechanisms of AVR obstruction: thrombus/
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pannus, mismatch, structural deterioration or indetermi-
nate. The criteria for an echocardiographic diagnosis of
obstructing thrombus/pannus were restriction in occluder
motion and/or an abnormal echogenic mass attached to the
prosthesis. A diagnosis of prosthesis–patient mismatch was
made if the AVR occluder motion and two-dimensional
images appeared normal. If imaging was inadequate to
identify a mechanism of obstruction the study was defined
as indeterminate.
TEE examinations were performed in 61 cases according
to previously published standards using commercially avail-
able systems (10,11), with multiplane probes in 27 cases
(44%), biplane probes in 21 (34%) and monoplane probes in
13 (21%). We recorded the TEE diagnosis of the mecha-
nism of obstruction as in the TTE studies and did not
attempt to differentiate pannus from thrombus. Intraoper-
ative (IO) TEE was performed at the surgeons’ discretion to
assist perioperative management.
Hemodynamic catheterization and fluoroscopy. After
echocardiography, the mean AVR pressure gradient was
determined by hemodynamic catheterization in 24 patients
(12), and the effective orifice area was estimated using the
Gorlin equation in 18 (13). Among 12 patients with a
mechanical AVR who underwent catheterization, the mean
gradient was determined by transseptal puncture (n 5 8),
direct left ventricular puncture (n 5 3) or retrograde passage
of a catheter across a ball-cage valve (n 5 1). Fluoroscopy
was performed in 16 of 49 (33%) patients with mechanical
AVR obstruction using previously reported methods (14).
Surgical and pathological examination. Prosthetic valve
complications were coded according to current guidelines
for reporting morbidity and mortality after cardiac valvular
operations (15). Based on direct surgical inspection and
pathological examination, the mechanism of obstruction
was classified as one of the following mutually exclusive
categories: thrombosis, pannus, mismatch or structural de-
terioration. Patients with predominantly thrombus and
minimal pannus were included in the thrombosis group;
those with predominantly pannus and minimal thrombus
were categorized in the pannus group.
Statistical analysis. Continuous variables were compared
using the Wilcoxon rank sum test, and categorical variables
were compared by the x2 test or Fisher exact test. To
analyze for time trends, two year groups were compared
using the Cochran–Armitage trend test. Pearson’s correla-
tion coefficient was used to compare continuous variables of
interest, and Cox proportional hazards model was used to
determine predictors of hospital mortality (SAS Institute,
Cary, North Carolina).
RESULTS
Clinical presentation of AVR obstruction. The clinical
profile of the study population (group A versus group B) is
presented in Tables 1 and 2. Group B patients were older
Abbreviations and Acronyms
AVR 5 aortic valve replacement
DVI 5 dimensionless velocity index
EOA 5 effective orifice area
MVR 5 mitral valve replacement
TEE 5 transesophageal echocardiography
TTE 5 transthoracic echocardiography
Table 1. Comparison of Medical History Data Between Group
A and Group B
Group A
(n 5 49)
Group B
(n 5 43) p*
Mean age 6 SD 56 6 14 64 6 15 0.004
Male gender, no. (%) 20 (41) 22 (51) 0.32
Prior myocardial infarction, no. (%) 3 (6) 8 (19) 0.07
Rheumatic heart disease, no. (%) 22 (45) 7 (16) 0.003
Congestive heart failure, no. (%)† 11 (22) 18 (42) 0.05
Prior endocarditis, no. (%) 5 (10) 5 (12) 1.00
Atrial fibrillation, no. (%) 19 (39) 10 (23) 0.11
NYHA functional class III or IV,
no. (%)
24 (49) 25 (58) 0.38
Presenting symptom, no. (%) 0.13
Asymptomatic 9 (18) 6 (14)
Dyspnea 26 (65) 31 (84)
Angina 11 (28) 5 (14)
Embolic phenomena 3 (8) 0 (0)
Syncope 0 (0) 1 (3)
Abnormal prosthetic sounds, no.
(%)‡
6 (12)
Radiographic pulmonary congestion,
no. (%)
17 (35) 17 (40) 0.63
*Wilcoxon rank sum test (continuous variables); x2 or Fisher exact test (categorical).
†History of NYHA class III or IV symptoms. ‡Absent or decreased mechanical valve
clicks.
AVR 5 aortic valve replacement; NYHA 5 New York Heart Association.
Table 2. Comparison of Surgical History Data Between Group
A and Group B
Group A
(n 5 49)
Group B
(n 5 53) p*
Previous cardiac operations,
no. (%)
0.12
1 29 (59) 31 (72)
2 16 (33) 11 (26)
3 4 (8) 0 (0)
4 0 (0) 1 (2)
Previous aortic valve operations,
no. (%)
0.58
1 44 (90) 37 (86)
2 5 (10) 6 (14)
Previous coronary artery bypass,
no. (%)
3 (6) 11 (26) 0.01
AVR type, no. (%)
Ball-cage 16 (33)
Tilting disk 24 (49)
Bileaflet 9 (18)
Bioprosthetic 43 (100)
Mean AVR size, 6 SD, mm 21 6 2 22 6 2 0.01
Mean time since AVR implant
6 SD, yr
13 6 8 7 6 4 , 0.001
Previous MVR, no. (%) 15 (31) 2 (5) 0.001
*Wilcoxon rank sum test (continuous variables); x2 or Fisher exact test (categorical).
AVR 5 aortic valve replacement; MVR 5 mitral valve replacement.
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than group A patients; they were also more likely to have a
history of congestive heart failure (CHF) or previous coro-
nary artery bypass surgery (CABG). Group A patients were
more likely to have rheumatic heart disease or a prior mitral
valve replacement (MVR) than group B patients. The
duration of symptoms before the diagnosis of AVR obstruc-
tion was .1 month in 60 of 77 (78%) patients who reported
symptoms, and only two patients (3%) reported symptoms
for ,1 week.
Doppler transthoracic echocardiography. Doppler TTE
correctly established the diagnosis of AVR obstruction in all
patients prior to fluoroscopy, TEE or hemodynamic cath-
eterization. A previous TTE examination was available in
45 patients. Thirty-six patients had an increase in the AVR
gradient (.10 mm Hg mean gradient or .20 mm Hg peak
gradient) compared to baseline, and nine had abnormal but
stable Doppler examinations. The median interval between
TTE and reoperation was 10 days (interquartile range 5–42
days). The ejection fraction, dimensionless velocity index
(DVI), EOA and mean AVR gradient did not vary between
the two groups (Table 3), but group B patients were more
likely to have aortic regurgitation.
Hemodynamic catheterization. The Gorlin effective pros-
thetic valve area was determined by catheterization at a
median of four days (interquartile range two to 15 days)
before reoperation in 18 patients (20%). There was a
significant correlation between the Doppler and catheter-
ization mean AVR gradient in these patients (R 5 0.50,
p 5 0.04). Although the catheterization rates did not vary
over time in group B patients, there was a marginally
significant trend (p 5 0.07) towards lower catheterization
rates in patients with mechanical AVR obstruction (Fig. 1).
Treatment of AVR obstruction. Among patients who had
repeat AVR implantation, which was the treatment in 95%
of the study cohort (Table 4), a mechanical valve was
implanted in 86% of group A and in 63% of group B
patients (p 5 0.01). Aortic annulus enlargement by the
Konno procedure or pericardial patch was performed in 43%
of group A and 23% of group B patients (p 5 0.05). Over
the study period, utilization of intraoperative (IO) TEE
increased from 9% to 80% in group A (p 5 0.001) and from
40% to 77% in group B patients (p 5 0.01).
Ten patients in the study group died in the hospital, but
there was no mortality (upper 95% CI 7.3%) among 49
patients treated for isolated AVR obstruction, including 17
who underwent the Konno procedure or pericardial patch
aortic root enlargement. Significant univariate predictors of
hospital mortality were a history of prior CABG (hazard
ratio 7.2; 95% CI 2.1–24.9) and concomitant CABG at
reoperation (hazard ratio 12.4; 95% CI 3.2–48.1).
Mechanism of mechanical AVR obstruction. The patho-
logic mechanism of mechanical AVR obstruction was pannus
overgrowth in 26 cases (53%), mismatch in 19 (39%) and
Figure 1. Temporal trends in hemodynamic catheterization rates for AVR
area among patients with prosthetic aortic valve (AVR) obstruction
undergoing reoperation. Filled circles 5 cases of mechanical AVR
obstruction. Cochran–Armitage Trend test p 5 0.07. Open circles 5 cases
of bioprosthetic AVR obstruction.
Table 3. Comparison of Echocardiographic Variables Between
Group A and Group B
Group A
(n 5 49)
Group B
(n 5 43) p*
Ejection fraction (%) 64 6 11 58 6 15 0.06
AVR mean gradient 6 SD,
mm Hg
50 6 17 48 6 17 0.69
DVI 6 SD 0.24 6 0.05 0.26 6 0.08 0.28
EOA 6 SD, cm2 0.85 6 0.25 0.93 6 0.26 0.19
Indexed EOA 6 SD, cm2/m2 0.46 6 0.11 0.49 6 0.13 0.36
Mean PA systolic pressure 6
SD, mm Hg
49 6 17 50 6 15 0.66
Aortic regurgitation, no. (%)† 5 (10) 17 (40) 0.001
Mitral regurgitation, no. (%)† 6 (12) 12 (28) 0.06
Tricuspid regurgitation, no. (%)† 11 (22) 4 (9) 0.09
Continuous data are represented as the mean 6 SD. *Wilcoxon rank sum test for
continuous variables and x2 test for categorical variables. †Moderate or severe
regurgitation.
AVR 5 aortic valve replacement; DVI 5 dimensionless velocity index; EOA 5
effective orifice area; PA 5 pulmonary artery.
Table 4. Comparison in the Treatment of AVR Obstruction
Between Group A and Group B
Group A
(n 5 49)
No. (%)
Group B
(n 5 43)
No. (%) p*
Treatment of AVR obstruction 0.12
Replace AVR 44 (90) 43 (100)
Resect pannus 4 (8) 0 (0)
Thrombectomy 1 (2) 0 (0)
Associated procedures
Septal myectomy 8 (16) 2 (5) 0.10
Konno procedure 4 (8) 0 (0) 0.12
Patch annulus enlargement 17 (35) 10 (23) 0.23
Concomitant surgery
Coronary artery bypass grafting 8 (16) 10 (23) 0.40
Aortic aneurysm surgery 3 (6) 4 (9) 0.70
Mitral valve surgery 12 (24) 5 (12) 0.11
Native mitral valve repair 2 (4) 0 (0)
Pannus resection or repair MVR 5 (10) 0 (0)
Implant MVR 3 (6) 4 (9)
Replace MVR 2 (4) 1 (2)
Tricuspid valve surgery 9 (18) 1 (2) 0.02
*x2 test or Fisher exact test.
AVR 5 aortic valve replacement; MVR 5 mitral valve replacement.
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thrombosis in four (8%). Minor quantities of pannus were
found in four cases of mechanical AVR thrombosis, but no
thrombus was identified in 26 cases of obstructing pannus.
Although Doppler TTE was crucial in diagnosing mechanical
AVR obstruction, TTE imaging correctly identified the
pathologic mechanism in only five of 49 (10%) studies (Table
5). Diagnostic TEE utilization averaged 47% of group A cases
and did not vary over time. The pathologic mechanism
(pannus/thrombus vs. mismatch) of mechanical AVR obstruc-
tion was correctly diagnosed in 17 of 35 cases (49%) by TEE.
There were 11 (33%) indeterminate TEE studies, and the
TEE mechanism of mechanical AVR obstruction was incor-
rect in 7 (20%). Nondiagnostic TEE images were attributed to
acoustic shadowing from a mechanical MVR in eight of 11
(73%) of the indeterminate cases. A TEE diagnosis of mis-
match was correct in 11 of 18 (61%) cases. We did not detect
a significant difference in the diagnostic accuracy of multiplane
versus monoplane or biplane TEE examinations.
The mean time from AVR implantation to treatment for
obstruction was 7.6 6 6 years in cases of mechanical
thrombosis, compared with 15 6 7 years (p 5 0.06) in cases
of pannus overgrowth and 11 6 8 years in cases of AVR
mismatch (p 5 0.49). All patients with mechanical pros-
theses had received chronic oral anticoagulation prior to the
diagnosis of AVR obstruction. The mean prothrombin time
was 23 6 8 s in cases of obstructive pannus, compared with
25 6 14 s in cases of mismatch (p 5 0.90) and 21 6 6 s in
cases of thrombosis (p 5 0.58).
Of 16 patients with mechanical AVR who underwent
preoperative cardiac fluoroscopy, the test was abnormal in three
of three (100%) patients with AVR thrombosis, five of eight
(63%) patients with pannus and zero of five (0%) patients with
mismatch. Among 12 patients who underwent TEE and
fluoroscopy, both studies were abnormal in four patients (three
with thrombosis, one with pannus), and both studies were
normal or indeterminate in six patients (three with mismatch,
three with pannus). Two patients with abnormal fluoroscopy
and indeterminate or normal TEE images had obstructing
pannus at surgery. There were no patients who had abnormal
TEE images and normal cardiac fluoroscopy.
Mechanism of bioprosthetic AVR obstruction. In group
B, the pathologic mechanism of obstruction was structural
deterioration in 37 (86%) cases, thrombosis in 3 (7%),
mismatch in 2 (5%) and pannus ingrowth in 1 (2%).
Two-dimensional TTE imaging correctly identified the
pathologic mechanism in 63% of cases (Table 6), and TEE
correctly identified the mechanism in 81% (p 5 0.18).
Utilization of diagnostic TEE averaged 21% of group B
cases and did not significantly vary over time.
DISCUSSION
Etiology of AVR obstruction. Prosthetic thrombosis has
been recognized as an important mode of mechanical valve
obstruction, leading to recommendations for thrombolytic
therapy in certain subsets of patients (16,17). However, the
proportion of mechanical AVR obstruction cases due to
acute thrombosis may vary markedly, depending on the
intensity of anticoagulation, prosthetic design and other
Table 5. Accuracy of TTE and TEE in Diagnosing the
Pathologic Mechanism of Mechanical AVR Obstruction
Mechanism of
Obstruction*
No. of Cases With TTE Diagnosis
Pannus/Thrombus Mismatch Indeterminate
Totals
Pannus 26 2 3 21
Mismatch 19 4 2 13
Thrombosis 4 1 — 3
No. of Cases With TEE Diagnosis†
Pannus/Thrombus Mismatch Indeterminate
Pannus 20 3 7 10
Mismatch 11 — 11 —
Thrombosis 4 3 — 1
*Diagnosed by surgical inspection and pathological examination. †TEE (diagnostic or
intraoperative) was performed in 35 of 49 group A cases.
AVR 5 aortic valve replacement; TEE 5 transesophageal echocardiography;
TTE 5 transthoracic echocardiography.
Table 6. Accuracy of TTE and TEE in Diagnosing the Pathologic Mechanism of Bioprosthetic
AVR Obstruction
Mechanism of
Obstruction*
No. of Cases With TTE Diagnosis
Structural Pannus/Thrombus Mismatch Indeterminate
Totals
Structural 37 27 — 2 8
Thrombosis 3 — — — 3
Pannus 1 — — — 1
Mismatch 2 2 — — —
No. of Cases With TEE Diagnosis†
Pannus/Thrombus Mismatch Indeterminate
Structural 21 19 — 1 1
Thrombosis 3 2 1 — —
Pannus 1 — — — 1
Mismatch 1 — — 1 —
*Diagnosed by surgical inspection and pathological examination. †TEE (diagnostic or intraoperative) was performed in 26 of 43
group B cases.
AVR 5 aortic valve replacement; TEE 5 transesophageal echocardiography; TTE 5 transthoracic echocardiography.
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factors (18). Deviri reported the mechanism of mechanical
valve obstruction as thrombus with little or no pannus in
78% of 106 cases, including both aortic and mitral prosthe-
ses (19). This is likely secondary to decreased intensity of
anticoagulation in the South African cohort of patients
compared to the patients in our study. More consistent with
our experience, Rizzoli reported pannus in 81% of 21 AVR
reoperations (20), and Barbetseas reported pannus in 70% of
10 cases of AVR obstruction (21).
Rahimtoola defined prosthesis-patient mismatch as a con-
dition in which high pressure gradients occur through normally
functioning prosthetic valves (22). Severe mismatch may result
in clinical symptoms and an increased hazard for major adverse
cardiac events in a manner analogous to the obstruction of
native valves (23). Therefore, we included prosthesis-patient
mismatch as a cause of obstruction, although these patients
were typically not reported in earlier series. Guidelines for
timing operation in patients with native aortic valve stenosis
may assist in the management of patients with presumed
mismatch and severe AVR obstruction (3).
Hemodynamic catheterization. Because of high false neg-
ative rates for fluoroscopy and for TTE before the availabil-
ity of Doppler echocardiography, Kontos concluded that
catheterization was the diagnostic procedure of choice in
suspected cases of prosthetic obstruction (24). Among cases
of mechanical AVR obstruction, we report a temporal trend
towards decreasing use of hemodynamic catheterization to
only 10% of cases in 1997 to 1998. There was no significant
decline in hemodynamic catheterization of patients with
bioprosthetic obstruction, likely because of convenient ac-
cess to the left ventricle at the time of coronary angiography.
However, even among patients with bioprosthetic obstruc-
tion, hemodynamic catheterization was infrequent—21% of
cases over the past decade. Thus, routine hemodynamic
catheterization of patients with suspected AVR obstruction
is not necessary. For patients with small (#21 mm) bileaflet
mechanical prostheses, hemodynamic catheterization may
be necessary to exclude significant pressure recovery, partic-
ularly if surgical therapy is contemplated for apparent
mismatch (25).
We attribute the modest correlation (R 5 0.50) between
catheter and Doppler mean prosthetic gradients to differ-
ences in autonomic tone and pharmacotherapy because the
studies were not performed simultaneously. Previous data
suggested a much stronger correlation between the tech-
niques when Doppler TTE was performed simultaneously
with the invasive hemodynamic measurements (12).
Role of transthoracic echocardiography. Doppler echo-
cardiography provides a quantitative, reproducible measure
of prosthetic obstruction, which is suggested by a progres-
sive increase in the prosthetic valve gradient and a decline in
the EOA or DVI (26–28). Doppler TTE was the initial
diagnostic test for all patients in our study, before fluoros-
copy, hemodynamic catheterization or TEE. Although
Doppler TTE is crucial in the identification of patients with
significant prosthetic obstruction, classification of the
pathologic mechanism of AVR obstruction is difficult using
TTE imaging alone.
Role of transesophageal echocardiography. TEE imag-
ing has been advocated to clarify the mechanism of pros-
thetic obstruction and to identify candidates for thrombo-
lytic therapy (29). Our results highlight the following
limitations of TEE in determining the pathologic mecha-
nism of mechanical AVR obstruction: nondiagnostic images
may result from acoustic shadowing in patients with me-
chanical mitral prostheses, and obstructing pannus over-
growth may not be visualized by TEE, particularly if the
occluder motion is not grossly restricted. The lower diag-
nostic accuracy of TEE in determining the pathological
mechanism of obstruction in our series compared with
previous studies may be attributed to several factors. First,
the sensitivity of imaging techniques depends on the severity
and mechanism of prosthetic obstruction. For instance,
massive acute AVR thrombosis is more readily diagnosed
than a small rim of obstructing pannus, and pannus was far
more common than thrombus in our series. Secondly, we
included cases of prosthesis-patient mismatch, a diagnosis
of exclusion confirmed only by surgical inspection and the
resolution of obstruction after implantation of a larger
prosthesis; previous series did not include these patients.
Finally, although we specifically sought to define the accu-
racy of TEE for clarifying the etiology of AVR obstruction,
other series have included both aortic and mitral prostheses.
Study limitations. Because we studied cases of AVR ob-
struction treated at a single tertiary medical institution over
the past decade, referral introduces several potential biases
that may limit the applicability of our results to other
centers. For instance, mechanical AVR thrombosis may be
underrepresented in our study if such patients received
thrombolytic therapy locally. However, only two patients
were treated with thrombolytics at our institution over this
same time period. We speculate that the small number of
patients in our study did not allow us to detect a significant
difference in the diagnostic accuracy of TEE examinations
conducted with multiplane versus biplane or monoplane
probes. Finally, the classification of a single pathologic
mechanism of obstruction is subjective and an oversimpli-
fication in some cases.
Clinical implications. We show that hemodynamic cath-
eterization is not necessary for the clinical management of
the majority of patients with AVR obstruction who undergo
reoperation. In a population of patients compulsive about
maintaining therapeutic anticoagulation, pannus over-
growth is a more common indication for mechanical AVR
reoperation than thrombosis. Although our results suggest
that a TEE or fluoroscopic diagnosis of mismatch is
provisional, empiric thrombolytic therapy in these patients
does not appear to be warranted. Only one of 29 (3%) group
A patients with normal or indeterminate TEE images had
AVR thrombosis at reoperation. Furthermore, patients
undergoing isolated AVR reoperation for obstruction, re-
gardless of the etiology, are at low risk—there was no
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hospital mortality in 49 consecutive cases at the Mayo
Clinic during the past decade (upper 95% CI of 7.3%).
Patients with suspected AVR obstruction should undergo
a comprehensive Doppler TTE examination because this is
the primary test to confirm or exclude obstruction. Trans-
esophageal echocardiography or fluoroscopy may be indi-
cated if thrombosis of an obstructed prosthesis is suspected
clinically and treatment with thrombolytics is contemplated.
However, a normal or indeterminate TEE does not confirm
a diagnosis of mismatch, as pannus may be present in a
significant proportion of these cases. Further studies are
needed to clarify the role of serial Doppler TTE examina-
tions for this group.
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